> Roche says that Thailand and the Philippines are free to make their own stockpiles of Tamiflu to protect their populations against a possible avian flu pandemic. Report
> Korea's drug agency has approved Dong-A's new therapy for ED. Report
> Nashville's BioMimetic Pharmaceuticals has been given FDA approval to market GEM 21S, a new treatment for bone defects in the jaws of patients with advanced periodontal disease. This is a first-in-class therapy. Report
> SeraCare Life Sciences will buy the medical test products division of Serologicals for $3.7 million and the assumption of unspecified liabilities. Report
> Enzon Pharmaceuticals and Germany's Micromet have ended a partnership to develop antibody-based drugs to combat inflammatory and autoimmune diseases. Enzon said the program no longer fits in its business plan, and Micromet gains control of the lead compound developed in the alliance, MT203. Report
> Antares Pharma will supply drug delivery devices to a division of Teva. Article
> Gedeon Richter and Forest Laboratories have expanded their alliance with two new collaborations for the treatment of various CNS conditions. Release
> Novartis has sold its dietary food business to a private equity group. Report
> Y's Therapeutics of Tokyo has launched a Phase II trial of YSPSL for prevention of delayed graft function in patients undergoing cadaveric kidney transplantation. Release
And Finally... LAM, an extremely rare lung disorder, has attracted few drug developers interested in finding a therapy for it. Article